Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer

The main goal of this clinical trial is to preliminary evaluate the efficacy of recombinant human IL-21-expressing oncolytic vaccinia virus injection (hV01) in patients with advanced pancreatic cancer.And the secondary purpose is to evaluate the safety of hV01.

Participants needed: 12
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Hangzhou Converd Co., Ltd.Updated: Feb 27, 2026Locations: 1
Eligibility criteria

Signing an informed consent form. [+5]

Acute toxic effects from prior treatments not resolved to Common Terminology Cri... [+6]

Status: Recruiting

A Study to Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Solid Tumors.

The purpose of this study is to evaluate the safety and primary efficacy of the combination therapy of recombinant human IL-21-expressing oncolytic vaccinia virus (hV01) and the PD-1 Inhibitor Tislelizumab in patients with advanced solid tumors.

Participants needed: 24
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Hangzhou Converd Co., Ltd.Updated: Sep 22, 2025Locations: 1
Eligibility criteria

Signing an informed consent form. [+7]

Receiving any of the following anti-tumor treatments within a specified time per... [+14]